VEMLIDY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Tenofovir Alafenamide Fumarate.
| Product ID | 61958-2301_071939d1-7479-4b7c-bde2-eff9f1019017 | 
| NDC | 61958-2301 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | VEMLIDY | 
| Generic Name | Tenofovir Alafenamide | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2016-11-10 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA208464 | 
| Labeler Name | Gilead Sciences, Inc. | 
| Substance Name | TENOFOVIR ALAFENAMIDE FUMARATE | 
| Active Ingredient Strength | 25 mg/1 | 
| Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2016-11-10 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA208464 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2016-11-10 | 
| Ingredient | Strength | 
|---|---|
| TENOFOVIR ALAFENAMIDE FUMARATE | 25 mg/1 | 
| SPL SET ID: | 72e6b33c-0351-4070-9172-eeaa186c01d2 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  VEMLIDY  86765021  5001852 Live/Registered | Gilead Sciences Ireland UC 2015-09-22 |